nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2A6—Ifosfamide—germ cell cancer	0.128	0.158	CbGbCtD
Azelastine—CYP2B6—Ifosfamide—germ cell cancer	0.0831	0.103	CbGbCtD
Azelastine—CYP3A5—Ifosfamide—germ cell cancer	0.0655	0.081	CbGbCtD
Azelastine—CYP2C8—Ifosfamide—germ cell cancer	0.0629	0.0779	CbGbCtD
Azelastine—CYP2C19—Ifosfamide—germ cell cancer	0.0528	0.0653	CbGbCtD
Azelastine—CYP2C9—Ifosfamide—germ cell cancer	0.0439	0.0543	CbGbCtD
Azelastine—CYP2B6—Cisplatin—germ cell cancer	0.0404	0.05	CbGbCtD
Azelastine—CYP2E1—Etoposide—germ cell cancer	0.0403	0.0498	CbGbCtD
Azelastine—ABCB1—Dactinomycin—germ cell cancer	0.0361	0.0446	CbGbCtD
Azelastine—CYP3A5—Etoposide—germ cell cancer	0.0313	0.0387	CbGbCtD
Azelastine—CYP2C8—Etoposide—germ cell cancer	0.0301	0.0372	CbGbCtD
Azelastine—CYP3A4—Ifosfamide—germ cell cancer	0.0255	0.0316	CbGbCtD
Azelastine—CYP1A2—Etoposide—germ cell cancer	0.0233	0.0288	CbGbCtD
Azelastine—ABCB1—Vinblastine—germ cell cancer	0.0226	0.028	CbGbCtD
Azelastine—CYP2C9—Cisplatin—germ cell cancer	0.0214	0.0264	CbGbCtD
Azelastine—CYP2D6—Vinblastine—germ cell cancer	0.0213	0.0263	CbGbCtD
Azelastine—ABCB1—Cisplatin—germ cell cancer	0.0207	0.0256	CbGbCtD
Azelastine—ABCB1—Etoposide—germ cell cancer	0.0204	0.0252	CbGbCtD
Azelastine—Mucosal ulceration—Ifosfamide—germ cell cancer	0.0176	0.128	CcSEcCtD
Azelastine—CYP3A4—Vinblastine—germ cell cancer	0.0135	0.0168	CbGbCtD
Azelastine—ABCB1—Methotrexate—germ cell cancer	0.0135	0.0166	CbGbCtD
Azelastine—CYP3A4—Etoposide—germ cell cancer	0.0122	0.0151	CbGbCtD
Azelastine—CYP2C9—cardial valve—germ cell cancer	0.00788	0.145	CbGeAlD
Azelastine—Ulcerative stomatitis—Dactinomycin—germ cell cancer	0.00299	0.0218	CcSEcCtD
Azelastine—Dysaesthesia—Ifosfamide—germ cell cancer	0.00292	0.0213	CcSEcCtD
Azelastine—Mucosal inflammation—Bleomycin—germ cell cancer	0.00267	0.0194	CcSEcCtD
Azelastine—Mucosal inflammation—Ifosfamide—germ cell cancer	0.00228	0.0166	CcSEcCtD
Azelastine—CYP2C19—urine—germ cell cancer	0.00219	0.0403	CbGeAlD
Azelastine—HRH3—brainstem—germ cell cancer	0.00214	0.0394	CbGeAlD
Azelastine—HRH3—telencephalon—germ cell cancer	0.0019	0.035	CbGeAlD
Azelastine—Mucosal inflammation—Etoposide—germ cell cancer	0.0018	0.0131	CcSEcCtD
Azelastine—CYP1A2—urine—germ cell cancer	0.00179	0.0329	CbGeAlD
Azelastine—CYP2C9—urine—germ cell cancer	0.0017	0.0312	CbGeAlD
Azelastine—CYP2E1—urine—germ cell cancer	0.00161	0.0296	CbGeAlD
Azelastine—Ulcer—Bleomycin—germ cell cancer	0.00156	0.0114	CcSEcCtD
Azelastine—Ulcer—Dactinomycin—germ cell cancer	0.00146	0.0106	CcSEcCtD
Azelastine—Amenorrhoea—Ifosfamide—germ cell cancer	0.00144	0.0105	CcSEcCtD
Azelastine—CYP1A1—skin epidermis—germ cell cancer	0.00143	0.0263	CbGeAlD
Azelastine—Furunculosis—Methotrexate—germ cell cancer	0.00141	0.0102	CcSEcCtD
Azelastine—Ageusia—Cisplatin—germ cell cancer	0.00135	0.00979	CcSEcCtD
Azelastine—Ulcerative stomatitis—Methotrexate—germ cell cancer	0.0013	0.00943	CcSEcCtD
Azelastine—CYP3A4—urine—germ cell cancer	0.0013	0.0238	CbGeAlD
Azelastine—CYP2D6—urine—germ cell cancer	0.00127	0.0234	CbGeAlD
Azelastine—Mouth ulceration—Dactinomycin—germ cell cancer	0.00125	0.00908	CcSEcCtD
Azelastine—Furuncle—Methotrexate—germ cell cancer	0.00122	0.00888	CcSEcCtD
Azelastine—HRH3—head—germ cell cancer	0.00118	0.0218	CbGeAlD
Azelastine—Ulcer—Cisplatin—germ cell cancer	0.00115	0.00839	CcSEcCtD
Azelastine—Arthritis—Bleomycin—germ cell cancer	0.00111	0.00804	CcSEcCtD
Azelastine—Mucosal inflammation—Methotrexate—germ cell cancer	0.00108	0.00786	CcSEcCtD
Azelastine—HRH3—cerebellum—germ cell cancer	0.00106	0.0194	CbGeAlD
Azelastine—Ulcer—Etoposide—germ cell cancer	0.00106	0.00768	CcSEcCtD
Azelastine—Atrial fibrillation—Ifosfamide—germ cell cancer	0.000969	0.00705	CcSEcCtD
Azelastine—Bronchospasm—Bleomycin—germ cell cancer	0.000913	0.00665	CcSEcCtD
Azelastine—Mouth ulceration—Etoposide—germ cell cancer	0.000903	0.00657	CcSEcCtD
Azelastine—Hypoaesthesia—Vinblastine—germ cell cancer	0.000875	0.00637	CcSEcCtD
Azelastine—Pharyngitis—Vinblastine—germ cell cancer	0.000873	0.00635	CcSEcCtD
Azelastine—Urinary retention—Ifosfamide—germ cell cancer	0.000873	0.00635	CcSEcCtD
Azelastine—HRH3—brain—germ cell cancer	0.000858	0.0158	CbGeAlD
Azelastine—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.000818	0.00595	CcSEcCtD
Azelastine—Haematuria—Bleomycin—germ cell cancer	0.000789	0.00574	CcSEcCtD
Azelastine—Bronchospasm—Ifosfamide—germ cell cancer	0.00078	0.00568	CcSEcCtD
Azelastine—Face oedema—Cisplatin—germ cell cancer	0.000764	0.00556	CcSEcCtD
Azelastine—Anaphylactoid reaction—Etoposide—germ cell cancer	0.000749	0.00545	CcSEcCtD
Azelastine—Hypoaesthesia—Bleomycin—germ cell cancer	0.000739	0.00538	CcSEcCtD
Azelastine—Pollakiuria—Ifosfamide—germ cell cancer	0.000733	0.00533	CcSEcCtD
Azelastine—Ill-defined disorder—Vinblastine—germ cell cancer	0.000711	0.00517	CcSEcCtD
Azelastine—Nasopharyngitis—Cisplatin—germ cell cancer	0.000708	0.00515	CcSEcCtD
Azelastine—KCNH2—trigeminal ganglion—germ cell cancer	0.0007	0.0129	CbGeAlD
Azelastine—Malaise—Vinblastine—germ cell cancer	0.000691	0.00503	CcSEcCtD
Azelastine—Flushing—Bleomycin—germ cell cancer	0.00069	0.00502	CcSEcCtD
Azelastine—Vertigo—Vinblastine—germ cell cancer	0.000688	0.00501	CcSEcCtD
Azelastine—Pharyngitis—Dactinomycin—germ cell cancer	0.000688	0.00501	CcSEcCtD
Azelastine—Conjunctivitis—Ifosfamide—germ cell cancer	0.000688	0.005	CcSEcCtD
Azelastine—Haematuria—Ifosfamide—germ cell cancer	0.000675	0.00491	CcSEcCtD
Azelastine—Hypertension—Vinblastine—germ cell cancer	0.000661	0.00481	CcSEcCtD
Azelastine—Herpes simplex—Methotrexate—germ cell cancer	0.000649	0.00472	CcSEcCtD
Azelastine—Glossitis—Methotrexate—germ cell cancer	0.000649	0.00472	CcSEcCtD
Azelastine—Discomfort—Vinblastine—germ cell cancer	0.000644	0.00469	CcSEcCtD
Azelastine—Flushing—Dactinomycin—germ cell cancer	0.000643	0.00468	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000639	0.00465	CcSEcCtD
Azelastine—Ulcer—Methotrexate—germ cell cancer	0.000633	0.0046	CcSEcCtD
Azelastine—ADRA1B—head—germ cell cancer	0.000631	0.0116	CbGeAlD
Azelastine—Bronchospasm—Etoposide—germ cell cancer	0.000616	0.00449	CcSEcCtD
Azelastine—Visual impairment—Ifosfamide—germ cell cancer	0.000612	0.00445	CcSEcCtD
Azelastine—Ill-defined disorder—Bleomycin—germ cell cancer	0.0006	0.00437	CcSEcCtD
Azelastine—Eye disorder—Ifosfamide—germ cell cancer	0.000593	0.00432	CcSEcCtD
Azelastine—Conjunctivitis—Cisplatin—germ cell cancer	0.000593	0.00431	CcSEcCtD
Azelastine—Flushing—Ifosfamide—germ cell cancer	0.000589	0.00429	CcSEcCtD
Azelastine—Malaise—Bleomycin—germ cell cancer	0.000583	0.00425	CcSEcCtD
Azelastine—Cough—Bleomycin—germ cell cancer	0.000564	0.00411	CcSEcCtD
Azelastine—Paraesthesia—Vinblastine—germ cell cancer	0.000561	0.00408	CcSEcCtD
Azelastine—HRH1—trigeminal ganglion—germ cell cancer	0.000561	0.0103	CbGeAlD
Azelastine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00056	0.00407	CcSEcCtD
Azelastine—Myalgia—Bleomycin—germ cell cancer	0.000551	0.00401	CcSEcCtD
Azelastine—Chest pain—Bleomycin—germ cell cancer	0.000551	0.00401	CcSEcCtD
Azelastine—KCNH2—telencephalon—germ cell cancer	0.000549	0.0101	CbGeAlD
Azelastine—Discomfort—Bleomycin—germ cell cancer	0.000544	0.00396	CcSEcCtD
Azelastine—Malaise—Dactinomycin—germ cell cancer	0.000544	0.00396	CcSEcCtD
Azelastine—Mouth ulceration—Methotrexate—germ cell cancer	0.000541	0.00394	CcSEcCtD
Azelastine—Constipation—Vinblastine—germ cell cancer	0.000535	0.00389	CcSEcCtD
Azelastine—Pain—Vinblastine—germ cell cancer	0.000535	0.00389	CcSEcCtD
Azelastine—Confusional state—Bleomycin—germ cell cancer	0.000532	0.00387	CcSEcCtD
Azelastine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000528	0.00384	CcSEcCtD
Azelastine—Visual impairment—Cisplatin—germ cell cancer	0.000528	0.00384	CcSEcCtD
Azelastine—Infection—Bleomycin—germ cell cancer	0.000524	0.00382	CcSEcCtD
Azelastine—Vision blurred—Ifosfamide—germ cell cancer	0.000521	0.00379	CcSEcCtD
Azelastine—Feeling abnormal—Vinblastine—germ cell cancer	0.000515	0.00375	CcSEcCtD
Azelastine—Myalgia—Dactinomycin—germ cell cancer	0.000514	0.00374	CcSEcCtD
Azelastine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000513	0.00373	CcSEcCtD
Azelastine—Eye disorder—Cisplatin—germ cell cancer	0.000512	0.00372	CcSEcCtD
Azelastine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000511	0.00372	CcSEcCtD
Azelastine—Flushing—Cisplatin—germ cell cancer	0.000508	0.0037	CcSEcCtD
Azelastine—Agitation—Ifosfamide—germ cell cancer	0.000508	0.0037	CcSEcCtD
Azelastine—Discomfort—Dactinomycin—germ cell cancer	0.000507	0.00369	CcSEcCtD
Azelastine—Hypoaesthesia—Etoposide—germ cell cancer	0.000499	0.00363	CcSEcCtD
Azelastine—Malaise—Ifosfamide—germ cell cancer	0.000499	0.00363	CcSEcCtD
Azelastine—CYP2A6—cerebellum—germ cell cancer	0.000498	0.00914	CbGeAlD
Azelastine—ABCB1—blood vessel—germ cell cancer	0.000497	0.00913	CbGeAlD
Azelastine—Vertigo—Ifosfamide—germ cell cancer	0.000497	0.00361	CcSEcCtD
Azelastine—Abdominal pain—Vinblastine—germ cell cancer	0.000494	0.0036	CcSEcCtD
Azelastine—Infection—Dactinomycin—germ cell cancer	0.000489	0.00356	CcSEcCtD
Azelastine—Palpitations—Ifosfamide—germ cell cancer	0.000489	0.00356	CcSEcCtD
Azelastine—HRH1—eye—germ cell cancer	0.000483	0.00888	CbGeAlD
Azelastine—Cough—Ifosfamide—germ cell cancer	0.000482	0.00351	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000481	0.0035	CcSEcCtD
Azelastine—Hypertension—Ifosfamide—germ cell cancer	0.000477	0.00347	CcSEcCtD
Azelastine—Paraesthesia—Bleomycin—germ cell cancer	0.000474	0.00345	CcSEcCtD
Azelastine—Dyspnoea—Bleomycin—germ cell cancer	0.000471	0.00343	CcSEcCtD
Azelastine—Myalgia—Ifosfamide—germ cell cancer	0.000471	0.00343	CcSEcCtD
Azelastine—Chest pain—Ifosfamide—germ cell cancer	0.000471	0.00343	CcSEcCtD
Azelastine—Eye disorder—Etoposide—germ cell cancer	0.000469	0.00341	CcSEcCtD
Azelastine—Flushing—Etoposide—germ cell cancer	0.000466	0.00339	CcSEcCtD
Azelastine—Discomfort—Ifosfamide—germ cell cancer	0.000465	0.00338	CcSEcCtD
Azelastine—Hypersensitivity—Vinblastine—germ cell cancer	0.000461	0.00335	CcSEcCtD
Azelastine—ADRA1B—brain—germ cell cancer	0.000457	0.0084	CbGeAlD
Azelastine—KCNH2—uterus—germ cell cancer	0.000456	0.00837	CbGeAlD
Azelastine—Confusional state—Ifosfamide—germ cell cancer	0.000455	0.00331	CcSEcCtD
Azelastine—Pain—Bleomycin—germ cell cancer	0.000451	0.00329	CcSEcCtD
Azelastine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000451	0.00328	CcSEcCtD
Azelastine—Vision blurred—Cisplatin—germ cell cancer	0.000449	0.00327	CcSEcCtD
Azelastine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000449	0.00327	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000449	0.00326	CcSEcCtD
Azelastine—Asthenia—Vinblastine—germ cell cancer	0.000448	0.00326	CcSEcCtD
Azelastine—Infection—Ifosfamide—germ cell cancer	0.000448	0.00326	CcSEcCtD
Azelastine—KCNH2—pituitary gland—germ cell cancer	0.000447	0.00822	CbGeAlD
Azelastine—CYP1A1—skin of body—germ cell cancer	0.000443	0.00814	CbGeAlD
Azelastine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000442	0.00322	CcSEcCtD
Azelastine—HRH1—telencephalon—germ cell cancer	0.00044	0.00809	CbGeAlD
Azelastine—Feeling abnormal—Bleomycin—germ cell cancer	0.000435	0.00317	CcSEcCtD
Azelastine—KCNH2—medulla oblongata—germ cell cancer	0.000432	0.00794	CbGeAlD
Azelastine—CYP2B6—skin of body—germ cell cancer	0.00043	0.00791	CbGeAlD
Azelastine—Malaise—Cisplatin—germ cell cancer	0.00043	0.00313	CcSEcCtD
Azelastine—Diarrhoea—Vinblastine—germ cell cancer	0.000428	0.00311	CcSEcCtD
Azelastine—Dysgeusia—Etoposide—germ cell cancer	0.000428	0.00311	CcSEcCtD
Azelastine—Fatigue—Dactinomycin—germ cell cancer	0.000424	0.00309	CcSEcCtD
Azelastine—CYP2E1—telencephalon—germ cell cancer	0.000423	0.00778	CbGeAlD
Azelastine—Back pain—Etoposide—germ cell cancer	0.000422	0.00307	CcSEcCtD
Azelastine—Pain—Dactinomycin—germ cell cancer	0.000421	0.00306	CcSEcCtD
Azelastine—HRH1—decidua—germ cell cancer	0.000417	0.00767	CbGeAlD
Azelastine—Body temperature increased—Bleomycin—germ cell cancer	0.000417	0.00304	CcSEcCtD
Azelastine—Dizziness—Vinblastine—germ cell cancer	0.000413	0.00301	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000411	0.00299	CcSEcCtD
Azelastine—CYP2C8—pituitary gland—germ cell cancer	0.000409	0.00752	CbGeAlD
Azelastine—Myalgia—Cisplatin—germ cell cancer	0.000406	0.00295	CcSEcCtD
Azelastine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000406	0.00295	CcSEcCtD
Azelastine—Paraesthesia—Ifosfamide—germ cell cancer	0.000405	0.00295	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—germ cell cancer	0.000405	0.00295	CcSEcCtD
Azelastine—Anxiety—Cisplatin—germ cell cancer	0.000404	0.00294	CcSEcCtD
Azelastine—CYP2A6—brain—germ cell cancer	0.000404	0.00743	CbGeAlD
Azelastine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000403	0.00293	CcSEcCtD
Azelastine—Dyspnoea—Ifosfamide—germ cell cancer	0.000402	0.00293	CcSEcCtD
Azelastine—Somnolence—Ifosfamide—germ cell cancer	0.000401	0.00292	CcSEcCtD
Azelastine—Discomfort—Cisplatin—germ cell cancer	0.000401	0.00292	CcSEcCtD
Azelastine—KCNH2—adrenal gland—germ cell cancer	0.0004	0.00735	CbGeAlD
Azelastine—Vomiting—Vinblastine—germ cell cancer	0.000397	0.00289	CcSEcCtD
Azelastine—KCNH2—midbrain—germ cell cancer	0.000395	0.00725	CbGeAlD
Azelastine—Malaise—Etoposide—germ cell cancer	0.000394	0.00287	CcSEcCtD
Azelastine—Vertigo—Etoposide—germ cell cancer	0.000392	0.00285	CcSEcCtD
Azelastine—Headache—Vinblastine—germ cell cancer	0.000392	0.00285	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—germ cell cancer	0.000389	0.00283	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—germ cell cancer	0.000389	0.00283	CcSEcCtD
Azelastine—Fatigue—Ifosfamide—germ cell cancer	0.000389	0.00283	CcSEcCtD
Azelastine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000389	0.00283	CcSEcCtD
Azelastine—Hypersensitivity—Bleomycin—germ cell cancer	0.000389	0.00283	CcSEcCtD
Azelastine—KCNH2—bone marrow—germ cell cancer	0.000387	0.00711	CbGeAlD
Azelastine—Infection—Cisplatin—germ cell cancer	0.000386	0.00281	CcSEcCtD
Azelastine—Constipation—Ifosfamide—germ cell cancer	0.000386	0.00281	CcSEcCtD
Azelastine—Pain—Ifosfamide—germ cell cancer	0.000386	0.00281	CcSEcCtD
Azelastine—KCNH2—spinal cord—germ cell cancer	0.000385	0.00708	CbGeAlD
Azelastine—CYP1A1—uterus—germ cell cancer	0.000385	0.00707	CbGeAlD
Azelastine—Cough—Etoposide—germ cell cancer	0.000381	0.00277	CcSEcCtD
Azelastine—Tachycardia—Cisplatin—germ cell cancer	0.00038	0.00276	CcSEcCtD
Azelastine—Asthenia—Bleomycin—germ cell cancer	0.000379	0.00276	CcSEcCtD
Azelastine—CYP2D6—brainstem—germ cell cancer	0.000378	0.00694	CbGeAlD
Azelastine—Hypertension—Etoposide—germ cell cancer	0.000377	0.00274	CcSEcCtD
Azelastine—CYP2B6—gonad—germ cell cancer	0.000376	0.00692	CbGeAlD
Azelastine—Asthma—Methotrexate—germ cell cancer	0.000375	0.00273	CcSEcCtD
Azelastine—Pruritus—Bleomycin—germ cell cancer	0.000374	0.00272	CcSEcCtD
Azelastine—KCNH2—female gonad—germ cell cancer	0.000373	0.00685	CbGeAlD
Azelastine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000372	0.00271	CcSEcCtD
Azelastine—Chest pain—Etoposide—germ cell cancer	0.000372	0.00271	CcSEcCtD
Azelastine—Nausea—Vinblastine—germ cell cancer	0.000371	0.0027	CcSEcCtD
Azelastine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000369	0.00268	CcSEcCtD
Azelastine—Discomfort—Etoposide—germ cell cancer	0.000367	0.00267	CcSEcCtD
Azelastine—CYP2C19—endocrine gland—germ cell cancer	0.000363	0.00668	CbGeAlD
Azelastine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000363	0.00264	CcSEcCtD
Azelastine—Confusional state—Etoposide—germ cell cancer	0.000359	0.00261	CcSEcCtD
Azelastine—Body temperature increased—Ifosfamide—germ cell cancer	0.000357	0.0026	CcSEcCtD
Azelastine—Abdominal pain—Ifosfamide—germ cell cancer	0.000357	0.0026	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—germ cell cancer	0.000356	0.00259	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000354	0.00258	CcSEcCtD
Azelastine—Infection—Etoposide—germ cell cancer	0.000354	0.00258	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—germ cell cancer	0.000353	0.00257	CcSEcCtD
Azelastine—Paraesthesia—Cisplatin—germ cell cancer	0.000349	0.00254	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000349	0.00254	CcSEcCtD
Azelastine—Tachycardia—Etoposide—germ cell cancer	0.000348	0.00253	CcSEcCtD
Azelastine—Dyspnoea—Cisplatin—germ cell cancer	0.000347	0.00252	CcSEcCtD
Azelastine—KCNH2—endocrine gland—germ cell cancer	0.000347	0.00637	CbGeAlD
Azelastine—KCNH2—head—germ cell cancer	0.000342	0.00629	CbGeAlD
Azelastine—Diarrhoea—Dactinomycin—germ cell cancer	0.000337	0.00245	CcSEcCtD
Azelastine—Vomiting—Bleomycin—germ cell cancer	0.000336	0.00244	CcSEcCtD
Azelastine—CYP2D6—telencephalon—germ cell cancer	0.000335	0.00616	CbGeAlD
Azelastine—Rash—Bleomycin—germ cell cancer	0.000333	0.00242	CcSEcCtD
Azelastine—Pain—Cisplatin—germ cell cancer	0.000333	0.00242	CcSEcCtD
Azelastine—Dermatitis—Bleomycin—germ cell cancer	0.000333	0.00242	CcSEcCtD
Azelastine—CYP2E1—medulla oblongata—germ cell cancer	0.000333	0.00611	CbGeAlD
Azelastine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000332	0.00242	CcSEcCtD
Azelastine—KCNH2—testis—germ cell cancer	0.000331	0.00607	CbGeAlD
Azelastine—CYP2B6—adrenal gland—germ cell cancer	0.000328	0.00603	CbGeAlD
Azelastine—Conjunctivitis—Methotrexate—germ cell cancer	0.000325	0.00237	CcSEcCtD
Azelastine—Asthenia—Ifosfamide—germ cell cancer	0.000324	0.00236	CcSEcCtD
Azelastine—Feeling abnormal—Cisplatin—germ cell cancer	0.000321	0.00233	CcSEcCtD
Azelastine—HRH1—adrenal gland—germ cell cancer	0.00032	0.00589	CbGeAlD
Azelastine—Paraesthesia—Etoposide—germ cell cancer	0.00032	0.00233	CcSEcCtD
Azelastine—Pruritus—Ifosfamide—germ cell cancer	0.000319	0.00232	CcSEcCtD
Azelastine—Haematuria—Methotrexate—germ cell cancer	0.000319	0.00232	CcSEcCtD
Azelastine—Dyspnoea—Etoposide—germ cell cancer	0.000318	0.00231	CcSEcCtD
Azelastine—CYP2C8—endocrine gland—germ cell cancer	0.000317	0.00583	CbGeAlD
Azelastine—Somnolence—Etoposide—germ cell cancer	0.000317	0.00231	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—germ cell cancer	0.000316	0.0023	CcSEcCtD
Azelastine—CYP1A1—female gonad—germ cell cancer	0.000315	0.00578	CbGeAlD
Azelastine—Nausea—Bleomycin—germ cell cancer	0.000314	0.00228	CcSEcCtD
Azelastine—Vomiting—Dactinomycin—germ cell cancer	0.000313	0.00228	CcSEcCtD
Azelastine—Rash—Dactinomycin—germ cell cancer	0.00031	0.00226	CcSEcCtD
Azelastine—Diarrhoea—Ifosfamide—germ cell cancer	0.000309	0.00225	CcSEcCtD
Azelastine—CYP2E1—adrenal gland—germ cell cancer	0.000308	0.00566	CbGeAlD
Azelastine—CYP3A5—female gonad—germ cell cancer	0.000308	0.00566	CbGeAlD
Azelastine—Body temperature increased—Cisplatin—germ cell cancer	0.000307	0.00224	CcSEcCtD
Azelastine—Fatigue—Etoposide—germ cell cancer	0.000307	0.00224	CcSEcCtD
Azelastine—ABCB1—trigeminal ganglion—germ cell cancer	0.000307	0.00564	CbGeAlD
Azelastine—KCNH2—cerebellum—germ cell cancer	0.000305	0.00561	CbGeAlD
Azelastine—Constipation—Etoposide—germ cell cancer	0.000305	0.00222	CcSEcCtD
Azelastine—Pain—Etoposide—germ cell cancer	0.000305	0.00222	CcSEcCtD
Azelastine—CYP2C8—testis—germ cell cancer	0.000302	0.00556	CbGeAlD
Azelastine—HRH1—female gonad—germ cell cancer	0.000299	0.00549	CbGeAlD
Azelastine—Dizziness—Ifosfamide—germ cell cancer	0.000298	0.00217	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—germ cell cancer	0.000298	0.00217	CcSEcCtD
Azelastine—CYP1A2—endocrine gland—germ cell cancer	0.000297	0.00545	CbGeAlD
Azelastine—CYP2E1—spinal cord—germ cell cancer	0.000297	0.00545	CbGeAlD
Azelastine—ABCB1—embryo—germ cell cancer	0.000296	0.00545	CbGeAlD
Azelastine—Feeling abnormal—Etoposide—germ cell cancer	0.000294	0.00214	CcSEcCtD
Azelastine—CYP1A1—endocrine gland—germ cell cancer	0.000293	0.00538	CbGeAlD
Azelastine—Nausea—Dactinomycin—germ cell cancer	0.000292	0.00213	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000291	0.00212	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—germ cell cancer	0.00029	0.00211	CcSEcCtD
Azelastine—CYP1A1—head—germ cell cancer	0.000289	0.00531	CbGeAlD
Azelastine—Vomiting—Ifosfamide—germ cell cancer	0.000287	0.00209	CcSEcCtD
Azelastine—Hypersensitivity—Cisplatin—germ cell cancer	0.000287	0.00209	CcSEcCtD
Azelastine—CYP3A5—endocrine gland—germ cell cancer	0.000286	0.00526	CbGeAlD
Azelastine—Rash—Ifosfamide—germ cell cancer	0.000284	0.00207	CcSEcCtD
Azelastine—CYP2B6—endocrine gland—germ cell cancer	0.000284	0.00523	CbGeAlD
Azelastine—Dermatitis—Ifosfamide—germ cell cancer	0.000284	0.00207	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—germ cell cancer	0.000282	0.00205	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—germ cell cancer	0.000282	0.00205	CcSEcCtD
Azelastine—CYP2C9—endocrine gland—germ cell cancer	0.000282	0.00518	CbGeAlD
Azelastine—CYP2B6—head—germ cell cancer	0.000281	0.00516	CbGeAlD
Azelastine—Eye disorder—Methotrexate—germ cell cancer	0.000281	0.00204	CcSEcCtD
Azelastine—Asthenia—Cisplatin—germ cell cancer	0.000279	0.00203	CcSEcCtD
Azelastine—HRH1—endocrine gland—germ cell cancer	0.000278	0.00511	CbGeAlD
Azelastine—HRH1—head—germ cell cancer	0.000274	0.00504	CbGeAlD
Azelastine—CYP2B6—testis—germ cell cancer	0.000271	0.00499	CbGeAlD
Azelastine—Nausea—Ifosfamide—germ cell cancer	0.000268	0.00195	CcSEcCtD
Azelastine—CYP2E1—endocrine gland—germ cell cancer	0.000267	0.00491	CbGeAlD
Azelastine—Diarrhoea—Cisplatin—germ cell cancer	0.000266	0.00194	CcSEcCtD
Azelastine—HRH1—testis—germ cell cancer	0.000265	0.00487	CbGeAlD
Azelastine—CYP2E1—head—germ cell cancer	0.000264	0.00484	CbGeAlD
Azelastine—Hypersensitivity—Etoposide—germ cell cancer	0.000263	0.00191	CcSEcCtD
Azelastine—ABCB1—retina—germ cell cancer	0.000262	0.00482	CbGeAlD
Azelastine—Dysgeusia—Methotrexate—germ cell cancer	0.000256	0.00186	CcSEcCtD
Azelastine—Asthenia—Etoposide—germ cell cancer	0.000256	0.00186	CcSEcCtD
Azelastine—CYP2E1—testis—germ cell cancer	0.000255	0.00468	CbGeAlD
Azelastine—Back pain—Methotrexate—germ cell cancer	0.000253	0.00184	CcSEcCtD
Azelastine—Pruritus—Etoposide—germ cell cancer	0.000252	0.00183	CcSEcCtD
Azelastine—KCNH2—brain—germ cell cancer	0.000248	0.00456	CbGeAlD
Azelastine—Vomiting—Cisplatin—germ cell cancer	0.000247	0.0018	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—germ cell cancer	0.000246	0.00179	CcSEcCtD
Azelastine—Rash—Cisplatin—germ cell cancer	0.000245	0.00178	CcSEcCtD
Azelastine—Dermatitis—Cisplatin—germ cell cancer	0.000245	0.00178	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—germ cell cancer	0.000244	0.00177	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000243	0.00177	CcSEcCtD
Azelastine—ABCB1—telencephalon—germ cell cancer	0.000241	0.00443	CbGeAlD
Azelastine—KCNH2—lymph node—germ cell cancer	0.00024	0.0044	CbGeAlD
Azelastine—Malaise—Methotrexate—germ cell cancer	0.000236	0.00172	CcSEcCtD
Azelastine—Dizziness—Etoposide—germ cell cancer	0.000236	0.00171	CcSEcCtD
Azelastine—CYP2E1—cerebellum—germ cell cancer	0.000235	0.00432	CbGeAlD
Azelastine—Vertigo—Methotrexate—germ cell cancer	0.000235	0.00171	CcSEcCtD
Azelastine—Nausea—Cisplatin—germ cell cancer	0.000231	0.00168	CcSEcCtD
Azelastine—ABCB1—decidua—germ cell cancer	0.000228	0.0042	CbGeAlD
Azelastine—Cough—Methotrexate—germ cell cancer	0.000228	0.00166	CcSEcCtD
Azelastine—CYP2D6—female gonad—germ cell cancer	0.000227	0.00418	CbGeAlD
Azelastine—CYP2C8—brain—germ cell cancer	0.000227	0.00417	CbGeAlD
Azelastine—Vomiting—Etoposide—germ cell cancer	0.000227	0.00165	CcSEcCtD
Azelastine—Rash—Etoposide—germ cell cancer	0.000225	0.00164	CcSEcCtD
Azelastine—Dermatitis—Etoposide—germ cell cancer	0.000224	0.00163	CcSEcCtD
Azelastine—Headache—Etoposide—germ cell cancer	0.000223	0.00162	CcSEcCtD
Azelastine—Chest pain—Methotrexate—germ cell cancer	0.000223	0.00162	CcSEcCtD
Azelastine—Myalgia—Methotrexate—germ cell cancer	0.000223	0.00162	CcSEcCtD
Azelastine—Discomfort—Methotrexate—germ cell cancer	0.00022	0.0016	CcSEcCtD
Azelastine—Confusional state—Methotrexate—germ cell cancer	0.000215	0.00157	CcSEcCtD
Azelastine—CYP3A4—endocrine gland—germ cell cancer	0.000215	0.00395	CbGeAlD
Azelastine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000213	0.00155	CcSEcCtD
Azelastine—Infection—Methotrexate—germ cell cancer	0.000212	0.00154	CcSEcCtD
Azelastine—Nausea—Etoposide—germ cell cancer	0.000212	0.00154	CcSEcCtD
Azelastine—CYP2D6—endocrine gland—germ cell cancer	0.000211	0.00388	CbGeAlD
Azelastine—CYP1A1—brain—germ cell cancer	0.000209	0.00385	CbGeAlD
Azelastine—CYP2D6—head—germ cell cancer	0.000209	0.00384	CbGeAlD
Azelastine—CYP2B6—brain—germ cell cancer	0.000203	0.00374	CbGeAlD
Azelastine—CYP1A1—lymph node—germ cell cancer	0.000202	0.00372	CbGeAlD
Azelastine—CYP2D6—testis—germ cell cancer	0.000202	0.0037	CbGeAlD
Azelastine—ABCB1—gonad—germ cell cancer	0.000201	0.0037	CbGeAlD
Azelastine—ABCB1—uterus—germ cell cancer	0.0002	0.00367	CbGeAlD
Azelastine—HRH1—brain—germ cell cancer	0.000199	0.00365	CbGeAlD
Azelastine—ABCB1—pituitary gland—germ cell cancer	0.000196	0.00361	CbGeAlD
Azelastine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000194	0.00142	CcSEcCtD
Azelastine—HRH1—lymph node—germ cell cancer	0.000192	0.00353	CbGeAlD
Azelastine—Paraesthesia—Methotrexate—germ cell cancer	0.000192	0.00139	CcSEcCtD
Azelastine—CYP2E1—brain—germ cell cancer	0.000191	0.00351	CbGeAlD
Azelastine—Dyspnoea—Methotrexate—germ cell cancer	0.00019	0.00138	CcSEcCtD
Azelastine—Somnolence—Methotrexate—germ cell cancer	0.00019	0.00138	CcSEcCtD
Azelastine—ABCB1—medulla oblongata—germ cell cancer	0.000189	0.00348	CbGeAlD
Azelastine—CYP2D6—cerebellum—germ cell cancer	0.000186	0.00342	CbGeAlD
Azelastine—Fatigue—Methotrexate—germ cell cancer	0.000184	0.00134	CcSEcCtD
Azelastine—Pain—Methotrexate—germ cell cancer	0.000183	0.00133	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—germ cell cancer	0.000176	0.00128	CcSEcCtD
Azelastine—ABCB1—adrenal gland—germ cell cancer	0.000175	0.00322	CbGeAlD
Azelastine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000175	0.00127	CcSEcCtD
Azelastine—ABCB1—midbrain—germ cell cancer	0.000173	0.00318	CbGeAlD
Azelastine—ABCB1—bone marrow—germ cell cancer	0.00017	0.00312	CbGeAlD
Azelastine—ABCB1—spinal cord—germ cell cancer	0.000169	0.0031	CbGeAlD
Azelastine—Abdominal pain—Methotrexate—germ cell cancer	0.000169	0.00123	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—germ cell cancer	0.000169	0.00123	CcSEcCtD
Azelastine—ABCB1—female gonad—germ cell cancer	0.000163	0.003	CbGeAlD
Azelastine—Hypersensitivity—Methotrexate—germ cell cancer	0.000157	0.00114	CcSEcCtD
Azelastine—Asthenia—Methotrexate—germ cell cancer	0.000153	0.00111	CcSEcCtD
Azelastine—ABCB1—endocrine gland—germ cell cancer	0.000152	0.00279	CbGeAlD
Azelastine—CYP2D6—brain—germ cell cancer	0.000151	0.00278	CbGeAlD
Azelastine—Pruritus—Methotrexate—germ cell cancer	0.000151	0.0011	CcSEcCtD
Azelastine—ABCB1—head—germ cell cancer	0.00015	0.00276	CbGeAlD
Azelastine—Diarrhoea—Methotrexate—germ cell cancer	0.000146	0.00106	CcSEcCtD
Azelastine—ABCB1—testis—germ cell cancer	0.000145	0.00266	CbGeAlD
Azelastine—Dizziness—Methotrexate—germ cell cancer	0.000141	0.00103	CcSEcCtD
Azelastine—Vomiting—Methotrexate—germ cell cancer	0.000136	0.000988	CcSEcCtD
Azelastine—Rash—Methotrexate—germ cell cancer	0.000135	0.000979	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—germ cell cancer	0.000134	0.000979	CcSEcCtD
Azelastine—ABCB1—cerebellum—germ cell cancer	0.000134	0.00246	CbGeAlD
Azelastine—Headache—Methotrexate—germ cell cancer	0.000134	0.000973	CcSEcCtD
Azelastine—Nausea—Methotrexate—germ cell cancer	0.000127	0.000923	CcSEcCtD
Azelastine—ABCB1—brain—germ cell cancer	0.000109	0.002	CbGeAlD
Azelastine—ABCB1—lymph node—germ cell cancer	0.000105	0.00193	CbGeAlD
